HealthShares(TM) Announces Change to the HealthShares(TM) Emerging Cancer Index
October 23 2007 - 5:40PM
PR Newswire (US)
NEW YORK, Oct. 23 /PRNewswire/ -- HealthShares(TM) Inc., an
investment company with a series of 20 underlying fund portfolios,
today announced it has been informed by Standard & Poor's, the
calculating agent for the HealthShares(TM) Indexes, that effective
at the opening of trading on Friday, October 26, 2007, Immunogen,
Inc. (NASDAQ:IMGN) will replace Bioenvision, Inc. (NASDAQ:BIVN) in
the HealthShares(TM) Emerging Cancer Index. Bioenvision, Inc. is
being acquired by Genzyme Corp. (NASDAQ:GENZ). Companies included
in the HealthShares(TM) Emerging Cancer Index are engaged in the
research, clinical development and/or commercialization of
therapeutic agents for the treatment of a wide variety of cancers.
About HealthShares(TM) XShares Advisors LLC, a financial services
company based in New York, is the creator of the HealthShares(TM)
family of Exchange Traded Funds (ETFs). HealthShares(TM) ETFs are
organized into therapeutic 'Verticals' and represent specific areas
of the healthcare, life science and biotechnology industries. Each
Vertical addresses a distinct sub-segment of healthcare, such as
the diagnosis and treatment of specific therapeutic areas (e.g.
cardiology, cancer, infectious disease, etc.) and the development
of medical devices (e.g. orthopedic repair, cardio devices, etc.).
Each ETF tracks an index of 22 stocks, except the Composite which
tracks 80 stocks, and offers institutional and individual investors
a more precise financial instrument that leverages the potential of
healthcare investing while mitigating the risks of single stock
picking. For more information, visit the website
http://www.healthsharesinc.com/. About XShares XShares Advisors
LLC, a subsidiary of XShares Group LLC, is a registered investment
advisor that provides investment advisory services to Exchange
Traded Funds. XShares also partners with major institutions and
index providers seeking to bring innovative Exchange Traded Funds
to market using its administrative platform. In addition, XShares
creates and licenses distinctive intellectual property for its
ETFs, developing products that allow for innovative trading
strategies and alternative investments for the financial community.
For more information, visit the website
http://www.xsharesadvisors.com/. An Investor should consider the
fund's investment objective, risks, charges and expenses carefully
before investing. For this and more complete information about the
fund call 800.925.2870 or visit the website
http://www.healthsharesinc.com/ for a prospectus. Please read the
prospectus carefully before investing. There are risks involved
with investing in ETFs including possible loss of money.
HealthShares(TM) are not actively managed and are subject to risks
similar to stocks, including those related to short selling and
margin maintenance. Losses from short sales may be unlimited, and
losses from purchases on margin may exceed original investment.
Normal brokerage commissions apply. HealthShares(TM) ETFs are
subject to increased risks associated with investing in a specific
sector compared to a more diversified investment, as well as unique
risks associated with the healthcare and biotechnology sector
(i.e., government regulation, patent regulation, etc.). The ETFs
face additional risks attributable to their investments in small
and medium capitalization companies, which are subject to higher
volatility than larger, more established companies. In addition,
they are invested in a limited number of securities and a decline
in the value of these investments would cause the fund's overall
value to decline to a greater degree than in a less concentrated
portfolio. Global or International Funds invest in foreign
securities that will be subject to certain risks not associated
with domestic securities, such as currency fluctuations, and
changes in political and economic conditions. The prospectus is not
an offer to buy or sell the portfolio shares, nor is the fund
soliciting an offer to buy its shares in any jurisdiction where the
offer or sale is not permitted. HealthShares(TM) Exchange Traded
Funds are distributed by ALPS Distributors, Inc. XShares Advisors
LLC and ALPS Distributors, Inc. are unaffiliated entities. HSI 345
exp. 12/31/07 DATASOURCE: HealthShares(TM) Inc. CONTACT: John T.
McInerney of Makovsky + Company, +1-212-508-9628, , for XShares
Advisors LLC Web site: http://www.xsharesadvisors.com/
http://www.healthsharesinc.com/
Copyright
Bioenvision (NASDAQ:BIVN)
Historical Stock Chart
From May 2024 to Jun 2024
Bioenvision (NASDAQ:BIVN)
Historical Stock Chart
From Jun 2023 to Jun 2024